Perfil
John Molesphini worked as Vice President-Manufacturing Engineering at Arthrocare Corp.
from 2011 to 2018 and as Executive Vice President-Operations at Apollo Endosurgery, Inc. from 2018 to 2023.
He received an undergraduate degree from Rensselaer Polytechnic Institute and an MBA from the University of Michigan.
Antiguos cargos conocidos de John Molesphini.
| Empresas | Cargo | Fin |
|---|---|---|
| APOLLO ENDOSURGERY, INC. | Director de Operaciones | 04/04/2023 |
| ARTHROCARE CORPORATION | Corporate Officer/Principal | 01/04/2018 |
Formación de John Molesphini.
| Rensselaer Polytechnic Institute | Undergraduate Degree |
| University of Michigan | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Arthrocare Corp.
 Arthrocare Corp. Medical SpecialtiesHealth Technology ArthroCare Corp. manufactures medical devices for cardiovascular, spinal and other medical treatments. The company was founded on April 29, 1993 and is headquartered in Memphis, TN. | Health Technology |
Apollo Endosurgery, Inc.
 Apollo Endosurgery, Inc. Medical SpecialtiesHealth Technology Apollo Endosurgery, Inc. is a medical technology company, which focuses on the design, development, and commercialization of medical devices to advance gastrointestinal therapeutic endoscopy. It offers Endoscopy, Surgical and Other products. The firm's endoscopy product portfolio consists of the OverStitch Endoscopic Suturing System, the OverStitch Sx Endoscopic Suturing System, and the Orbera Intragastric Balloon System. Its products are used by gastroenterologists and bariatric surgeons in a variety of settings to treat multiple gastrointestinal conditions including closure of acute perforations and chronic fistulas, inadvertent perforation of the GI tract, tissue closure after the removal of abnormal lesions in the esophagus, stomach or colon, the treatment of swallowing disorders, esophageal stent fixation, and obesity. The company was founded by Christopher J. Gostout and Dennis L. McWilliams in 2005 and is headquartered in Austin, TX. | Health Technology |
- Bolsa de valores
- Insiders
- John Molesphini